Compare GraniteShares 2x Long NVDA Daily ETF (NVDL) vs GeneDx Holdings Corp (WGS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GraniteShares 2x Long NVDA Daily ETF vs GeneDx Holdings Corp — how do they compare? GraniteShares 2x Long NVDA Daily ETF trades at $31.37, while GeneDx Holdings Corp trades at $61.92 (market cap $1.80B). The key difference: GraniteShares 2x Long NVDA Daily ETF is trading nearer its 52-week high, GeneDx Holdings Corp nearer its low. Which is the better fit depends on your goals.
| NVDL | WGS | |
|---|---|---|
Sector | Leveraged / Inverse | Technology |
52-Week High | $43.02 | $167.51 |
52-Week Low | $21.76 | $34.51 |
Market Cap | — | $1.80B |
Enterprise Value | — | $1.80B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
NVDL, the GraniteShares 2x Long NVDA Daily ETF, trades at $30.51 with a 0.76% daily gain, though technical indicators signal a bearish trend. The fund provides 2x daily leveraged exposure to NVIDIA's stock performance, experiencing significant volatility with a recent 12% single-day drop. Recent corporate actions include two 1:3 stock splits scheduled for June 2026.
The outlook remains tied to NVIDIA's AI-driven growth but carries substantial risk from daily leverage reset mechanics. While the fund has delivered strong YTD returns of 12.66%, historical volatility highlights the compounding risks during market downturns. Investors face amplified losses during NVIDIA price declines despite potential for outsized gains in bullish periods.
GeneDx Holdings (WGS) trades at $60.65, down 4.46% today, amid a bearish technical signal and multiple class-action lawsuits alleging securities fraud. The stock shows weak fundamentals with a negative net income margin of -17.58% and ROE of -30.42%, though it beat EPS estimates in two of the last three quarters. Revenue grew to $427.54M in 2025 but profitability remains a challenge, with a high EV/EBITDA of 161.17 indicating stretched valuation relative to earnings.
Despite a 90.9% analyst buy rating and a $75.40 consensus price target, significant risks from litigation and persistent losses cloud the outlook. The stock faces near-term pressure from legal overhangs, while operational cash flow turned negative in 2026. Investors should weigh high analyst optimism against substantial fundamental and legal headwinds before considering a position.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About GraniteShares 2x Long NVDA Daily ETF
NVDL is a leveraged ETF that seeks daily investment results corresponding to 200% (2x) of the daily performance of NVIDIA Corporation (NVDA) stock. It is designed as a tactical trading tool for investors with a strong bullish (long) view on NVDA. Due to the effects of compounding and leverage, the ETF is intended to be held for a single day and is not suitable for long-term investment, as its performance over longer periods may significantly deviate from two times the performance of the NVDA stock.
Read more on NVDL →About GeneDx Holdings Corp
GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →
